Teva Pharmaceutical Inds LTD (TEVA) Shareholder Abrams Capital Management LP Decreased Holding as Valuation Declined; As General Electric Co (GE) Share Value Declined, Holder Holderness Investments Company Decreased by $498,814 Its Holding

May 21, 2018 - By Dolores Ford

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Logo

Holderness Investments Company decreased its stake in General Electric Co (GE) by 24.95% based on its latest 2017Q4 regulatory filing with the SEC. Holderness Investments Company sold 29,342 shares as the company’s stock declined 23.20% with the market. The institutional investor held 88,245 shares of the consumer electronics and appliances company at the end of 2017Q4, valued at $1.54 million, down from 117,587 at the end of the previous reported quarter. Holderness Investments Company who had been investing in General Electric Co for a number of months, seems to be less bullish one the $133.84 billion market cap company. The stock increased 2.94% or $0.44 during the last trading session, reaching $15.41. About 45.95 million shares traded. General Electric Company (NYSE:GE) has declined 54.35% since May 21, 2017 and is downtrending. It has underperformed by 65.90% the S&P500.

David Abrams decreased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 8.7% based on its latest 2017Q4 regulatory filing with the SEC. Abrams Capital Management Lp sold 1.88M shares as the company’s stock declined 11.04% with the market. The hedge fund run by David Abrams held 19.74 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $374.13 million, down from 21.62 million at the end of the previous reported quarter. Abrams Capital Management Lp who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be less bullish one the $21.46B market cap company. The stock decreased 0.73% or $0.1544 during the last trading session, reaching $21.0756. About 4.75M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 49.50% since May 21, 2017 and is downtrending. It has underperformed by 61.05% the S&P500.

More notable recent General Electric Company (NYSE:GE) news were published by: Seekingalpha.com which released: “3D printing for the military at GE” on May 02, 2018, also Schaeffersresearch.com with their article: “Weekly Call Options Hot as Micron, GE Stocks Push Higher” published on May 21, 2018, Seekingalpha.com published: “General Electric: Selling Low?” on May 17, 2018. More interesting news about General Electric Company (NYSE:GE) were released by: Seekingalpha.com and their article: “Wabtec and GE Transportation to merge” published on May 21, 2018 as well as Seekingalpha.com‘s news article titled: “GE: Exhaustion In A Corporate Restructuring” with publication date: May 21, 2018.

Since January 26, 2018, it had 1 buy, and 0 insider sales for $43,446 activity.

Investors sentiment decreased to 0.5 in Q4 2017. Its down 0.19, from 0.69 in 2017Q3. It dived, as 153 investors sold GE shares while 921 reduced holdings. 151 funds opened positions while 383 raised stakes. 4.69 billion shares or 0.29% less from 4.70 billion shares in 2017Q3 were reported. 16,950 were reported by Pring Turner Gp. New England Private Wealth Lc reported 0.23% in General Electric Company (NYSE:GE). Old Mutual Customised Solutions (Proprietary) Ltd owns 174,881 shares. Cheviot Value Limited Liability owns 143,992 shares or 1.3% of their US portfolio. Strategic Fincl Svcs invested 0.21% of its portfolio in General Electric Company (NYSE:GE). Goldman Sachs Group Inc reported 48.20 million shares. Somerset holds 0.01% or 644 shares. Evergreen Mngmt Lc has invested 0.14% in General Electric Company (NYSE:GE). Citadel Limited Liability Company reported 19.82 million shares stake. First State Bank reported 0.49% in General Electric Company (NYSE:GE). Fort Washington Invest Advsr Incorporated Oh stated it has 4.19 million shares or 0.73% of all its holdings. 89,788 are held by Portland Advisors Limited Liability Company. Papp L Roy & holds 34,914 shares or 0.12% of its portfolio. Linscomb And Williams Inc reported 291,921 shares stake. 151,600 were accumulated by Stuyvesant Cap Mngmt.

Analysts await General Electric Company (NYSE:GE) to report earnings on July, 20. They expect $0.18 EPS, down 35.71% or $0.10 from last year’s $0.28 per share. GE’s profit will be $1.56B for 21.40 P/E if the $0.18 EPS becomes a reality. After $0.16 actual EPS reported by General Electric Company for the previous quarter, Wall Street now forecasts 12.50% EPS growth.

Among 29 analysts covering General Electric Company (NYSE:GE), 9 have Buy rating, 6 Sell and 14 Hold. Therefore 31% are positive. General Electric Company had 102 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of General Electric Company (NYSE:GE) earned “Hold” rating by Stifel Nicolaus on Tuesday, April 3. Morgan Stanley maintained the stock with “Equal-Weight” rating in Monday, October 2 report. Deutsche Bank maintained it with “Sell” rating and $15.0 target in Tuesday, November 21 report. The rating was maintained by Stifel Nicolaus on Sunday, December 10 with “Hold”. The firm has “Sell” rating by J.P. Morgan given on Monday, April 9. The firm has “Sell” rating by Deutsche Bank given on Monday, October 30. The stock of General Electric Company (NYSE:GE) earned “Hold” rating by Bank of America on Monday, January 22. On Thursday, May 12 the stock rating was initiated by JP Morgan with “Underweight”. Cowen & Co initiated the shares of GE in report on Tuesday, June 7 with “Market Perform” rating. The stock of General Electric Company (NYSE:GE) has “Outperform” rating given on Monday, November 23 by Credit Suisse.

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Seekingalpha.com which released: “Teva: Israeli Judge Delays Layoffs At Ashdod Plant” on April 30, 2018, also Fool.com with their article: “Why Teva Pharmaceutical Industries, Gramercy Property Trust, and Medtronic Jumped Today” published on May 07, 2018, Globes.Co.Il published: “Teva on FDA name and shame list” on May 21, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Globes.Co.Il and their article: “FDA delays approving Perrigo’s generic Teva inhaler” published on May 13, 2018 as well as Globes.Co.Il‘s news article titled: “Mon: Teva rally lifts TASE” with publication date: May 14, 2018.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 153 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Hold” rating by RBC Capital Markets on Sunday, March 25. On Thursday, June 22 the stock rating was maintained by Cantor Fitzgerald with “Hold”. The firm has “Outperform” rating by Cowen & Co given on Wednesday, April 5. The firm earned “Underperform” rating on Friday, February 9 by Leerink Swann. The company was maintained on Monday, May 7 by Mizuho. The stock has “Outperform” rating by Leerink Swann on Tuesday, July 21. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, July 29. RBC Capital Markets maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, November 3 with “Underperform” rating. Citigroup maintained the stock with “Buy” rating in Tuesday, July 28 report. Morgan Stanley reinitiated Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Wednesday, July 29. Morgan Stanley has “Overweight” rating and $85.0 target.

Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on August, 2. They expect $0.59 earnings per share, down 40.40% or $0.40 from last year’s $0.99 per share. TEVA’s profit will be $600.76M for 8.93 P/E if the $0.59 EPS becomes a reality. After $0.91 actual earnings per share reported by Teva Pharmaceutical Industries Limited for the previous quarter, Wall Street now forecasts -35.16% negative EPS growth.

General Electric Company (NYSE:GE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: